Cancer death toll lowest for 40 years

The number of deaths from three of the most common cancers in the UK has dropped to its lowest level for nearly 40 years....

SmPC approval for Viramune

Boehringer Ingelheim has received approval for an update of the summary of product characteristics (SmPC) for Viramune (nevirapine) as a treatment for patients with...

Government commits to support health innovation

A new Blueprint to put innovation at the heart of healthcare delivery has been launched by the Office for Life Sciences (OLS). The Blueprint...

Gloves for burned hands

Ark Therapeutics Group has launched Kerraglove, a mitten-shaped dressing device to manage exudate in hand burns, in the UK. Designed for use in...

Text messaging services in primary care

A patient text messaging service designed to address the problem of non-attendance is being launched by NHS Wirral. The new system, from London-based...

MPs raise adverse incident concerns

A Government health select committee has warned that England's current patient safety policy has serious weaknesses. The committee's report stresses the need for...

Smart Toe sets foot in UK

French orthopaedic company Memometal Technologies is opening a sales office in London in August 2009. The company's leading product Smart Toe, an orthopaedic...

Covidien ranked number 1 for innovation

Healthcare corporation Covidien has been ranked the top innovator in the U.S. medical devices and services industry by the Patent Board, the official patent...

Surrey hospital chooses Symbia T6

St Helier Hospital, part of Epsom and St Helier University Hospitals NHS Trust, has installed a SPECT•CT scanner that promises "a greater depth of...

Medtech SMEs to benefit from Innovation Fund

The creation of a new investment fund to boost technology businesses with high growth potential has been welcomed by the medtech industry. The UK...

Latest articles

Image of two business people shaking hands in front of a contract to show NICE recommends ADCETRIS (brentuximab vedotin), in combination with chemotherapy, as frontline treatment for a rare type of lymphoma

NICE recommends ADCETRIS▼ (brentuximab vedotin), in combination with chemotherapy, as frontline treatment for a...

Takeda UK has announced that the National Institute for Health and Care Excellence (NICE) has recommended ADCETRIS (brentuximab vedotin) with cyclophosphamide, doxorubicin and prednisone...
Image of a briefcase and papers to show CMA formally concludes fludrocortisone investigation

CMA formally concludes fludrocortisone investigation

The Competition and Markets Authority (CMA) has formally concluded its fludrocortison investigation and found that three pharmaceutical companies took part in an illegal arrangement...
Image of a pharmacist holding tablets to show MHRA response to Independent Medicines and Medical Devices Safety Review

MHRA response to Independent Medicines and Medical Devices Safety Review

The Medicines and Healthcare products Regulatory Agency (MHRA) has published its response to the Independent Medicines and Medical Devices Safety Review. In its response, the...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
IMage of a doctor and patient in front of a heart with trace to show First Do No Harm: Independent Medicines and Medical Devices Safety Review publishes its recommendations

First Do No Harm: Independent Medicines and Medical Devices Safety Review publishes its recommendations

The Independent Medicines and Medical Devices Safety Review, chaired by Baroness Julia Cumberlege, has today published its report. Titled 'First Do No Harm', it comes...
Image of a contract being signed by two people with a certification stamp to show European Commission approves extended Invokana ® (canagliflozin) indication

European Commission approves extended Invokana ® (canagliflozin) indication

The European Commission has approved an extended Invokana ® (canagliflozin) indication to reflect improved renal outcomes in patients with diabetic kidney disease and type...

Pancreatic Cancer Story: James Dadge

James, 44, lives in Manchester with his partner Andrea and sons Ben and Daniel. He was diagnosed with a neuroendocrine tumour, with the primary...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription